Industries - In-Vitro Diagnostic Substance Manufacturing

We now have Quarter 2 H1B visa FY 2023 data and Quarter 2 PERM visa FY 2023 data.

In-Vitro Diagnostic Substance Manufacturing (NAICS code 325413) has an average growth rate of 0.42% as an H1B industry with 367 employees hired as of 2022

Top In-Vitro Diagnostic Substance Manufacturing Employers

Company	Employees	Average Wage
Sysmex America, Inc.	28	$99,006
Ctk Biotech Inc.	18	$55,216
Microbiologics, Inc	17	$58,727
Diasorin Molecular Llc	12	$92,975
Leica Biosystems Richmond, Inc.	12	$93,151
Seer, Inc.	12	$107,690
Informed Data Systems Inc.	11	$119,606
Syntron Bioresearch, Inc.	10	$47,767
Celldex Therapeutics, Inc.	7	$114,905
Hygiena Marketing Llc	7	$91,110

Top In-Vitro Diagnostic Substance Manufacturing Jobs

Job Title	Number of Jobs	Average Wage
Software Developers, Applications	40	$106,072
Biological Scientists, All Other	27	$58,662
Chemists	24	$62,615
Biological Technicians	22	$43,162
Biomedical Engineers	21	$89,470
Industrial Engineers	14	$92,475
Biochemists And Biophysicists	13	$75,882
Medical Scientists, Except Epidemiologists	13	$78,793
Microbiologists	12	$63,171
Accountants And Auditors	7	$54,858

Employees Over Time vs Average Salary Over Time

The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where 6 employees were hired. They peaked in 2022 with 80 employees, and have since been on a decline with the most recent number of employees being 17 in 2023.

The In-vitro Diagnostic Substance Manufacturing industry has been in the H1B Visa program since 2011 where the average salary was $49,299. The industry peaked in 2023 with an average salary of $102,283, and the recent trend shows the average salary on an incline.